This executive summary outlines the proceedings of the 3rd AFNET/EHRA consensus conference on atrial fibrillation management, focusing on risk factors, classification, monitoring, and antithrombotic therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lip et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: